Mometason-Mepha Nasenspray, Suspension

7680632480017 CH-63248 suspension
Mometason-Mepha Nasenspray, Suspension
Mometason-Mepha Nasenspray, Suspension
Mometason-Mepha Nasenspray, Suspension
1 / 3
google

Article details

Package size
140
Selling units
140
Measure
Einzeldose(n)
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/06/2024
Patient information leaflet
Français
03/06/2024
Patient information leaflet
Italien
03/06/2024
Summary of Product Characteristics
Allemand
03/06/2024
Summary of Product Characteristics
Français
03/06/2024
Summary of Product Characteristics
Italien
03/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
20.0 UG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 17.65
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2014

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
63248
Drug name
Mometason-Mepha Nasenspray, Suspension
Galenic form
NASSS
ATC Code
R01AD09
Authorization status
Z
Dispensing category
B
First authorization
07/02/2014
Authorization expiration date
31/12/9999
IT Number
12.02.3.
Domain
Human medicine
Field of application
Rhinitis, Nasenpolypen

Package details

Description (FR)
MOMETASON Mepha spray nasal 50 mcg 140 dos
Description (DE)
MOMETASON Mepha Nasenspray 50 mcg 140 Dos
Market launch
07/02/2014
Narcotic (BTM)
No

Original drug

Nasonex, Dosier-Nasenspray
GTIN: 7680541890365
CHF 18.45
View original

Other package sizes (1)

MOMETASON Mepha spray nasal 50 mcg 3 x 140 dos
3 x 140 EINZ
GTIN: 7680632480024
View